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An increased risk of ALS has been reported for veterans, varsity athletes, and professional football players. The mechanism
underlying the increased risk in these populations has not been identified; however, it has been proposed that motor nerve
injury may trigger immune responses which, in turn, can accelerate the progression of ALS. Accumulating evidence indicates
that abnormal immune reactions and inflammation are involved in the pathogenesis of ALS, but the specific immune cells involved
have not been clearly defined. To understand how nerve injury and immune responses may contribute to ALS development, we
investigated responses of CD4+ T cell after facial motor nerve axotomy (FNA) at a presymptomatic stage in a transgenic mouse
model of ALS (B6SJL SOD1G93A). SOD1G93A mice, compared with WT mice, displayed an increase in the basal activation state
of CD4+ T cells and higher frequency of Th17 cells, which were further enhanced by FNA. In conclusion, SOD1G93A mice exhibit
abnormal CD4+ T cell activation with increased levels ofTh17 cells prior to the onset of neurological symptoms.Motor nerve injury
exacerbatesTh17 cell responses and may contribute to the development of ALS, especially in those who carry genetic susceptibility
to this disease.
1. Introduction
An increased risk of ALS is associated with certain popula-
tions who have a history of extensive physical contact such
as varsity athletics, professional soccer players, and military
veterans [1–3].Motor nerve injury as a trigger to degeneration
has been proposed in these populations, but the underlying
mechanism remains elusive. In order to investigate this
hypothesis, we utilized the motor nerve injury (facial nerve
axotomy (FNA)) in the ALS mouse model (SOD1G93A mice)
to evaluate the impact of FNA on motoneuron survival after
injury. We found that FNA-induced motor neuron loss is sig-
nificantly increased in SOD1G93A mice relative to WT mice.
Importantly, the increased motor neuron loss in SOD1G93A
mice can be prevented by adoptive transfer of immune cells
from wild-type mice [4]. These data suggest that individuals
with a genetic susceptibility to ALS are more vulnerable to
nerve injury-induced neurodegeneration. Because such vul-
nerability is impacted by the immune system, we hypothesize
that FNA may induce a more pronounced proinflammatory
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response in SOD1G93A mice than in WT mice, which in turn
impairs the function of neuroprotective immune responses
[4].
As the pivotal cell of immunoregulation, the CD4+ T
cell has been of a great interest in the investigation of the
pathogenesis of ALS. CD4+ T cells have several subsets
with distinct immunoregulatory functions. In late-stage ALS
patients, the total number of na¨ıve CD4+ T cells is decreased
and CD4+ T cell infiltration in the spinal cord and brain is
significantly increased [5, 6]. In addition, elevated Th1 cells
in cerebrospinal fluid and elevated IL-17 and Th17-related
cytokines (IL-6, TNF-𝛼, IL-1, and IL-23) [7–9] in the serum
have also been observed in ALS patients. Furthermore, the
level of antineuroinflammatory subsets, Th2 and Treg cells
[10, 11], appear to regulate the speed of disease progression.
However, the roles of proneuroinflammatory subsets, Th1
and Th17 cells, in promoting ALS development has yet to
be established due to two challenges: late diagnosis and the
chronic nature of the disease. The late diagnosis makes it
difficult to conclude whether observed abnormal immune
response and inflammation are the cause or the result of the
disease. The chronic nature of ALS also makes it difficult
to determine the best timing for the detection of such
autoimmune responses.
We have previously demonstrated that FNA is capable
of inducing a readily detectable immune response in a
predictable time period (7–14 days) [12]. In the current study,
we performed FNA in presymptomatic B6SJL SOD1G93A
mice (8-week-old) and examined CD4+ T responses in a time
course after FNA. We found that abnormal CD4+ T cell acti-
vation with increasedTh17 cells is present in SOD1G93A mice
prior to the onset of neurological symptoms. FNA further
exacerbates CD4+ T cell activation and Th17 cell responses
in SOD1G93A mice.These results suggest that SOD1G93A mice
have impaired immunoregulatorymechanisms that normally
dampen injury-induced inflammatory responses and that
Th17 cell-promoted inflammation might contribute to the
increase in injury-induced motoneuron death in SOD1G93A
mice.
2. Materials and Methods
2.1. Animals and Surgical Procedures. Six-week-old female
B6SJL SOD1G93A and wild-type female B6SJLF1/J mice
were obtained from Jackson Laboratory (Sacramento, CA,
USA). All mice were housed and surgery was performed as
previously described [4, 12]. All surgical procedures were
completed in accordance with National Institutes of Health
guidelines on the care and use of laboratory animals for
research purposes.
2.2. Preparation of CD4+ T Cells. The right cervical lymph
nodes (draining cervical lymph node (dCLN)) were collected
from uninjured (control) or axotomized mice (𝑛 = 4/group)
at 7, 9, and 14 days postaxotomy (dpa). CD4+ T cells were
isolated via autoMACS using anti-CD4 magnetic beads as
previously described [4, 12].
2.3. Flow Cytometric Staining and Analysis. CD4+ T cells
separated from the draining cervical lymph node preparation
were incubated for 6 hours with phorbol myristate acetate
(PMA, 50 ng/mL) and ionomycin (500 ng/mL, P/I, Sigma,
St. Louis, MO) with brefeldin A (BFA, 10𝜇g/mL, Sigma,
St. Louis, MO) added during the final 2 hours. For the
intracellular staining, CD4+ T cells were permeabilized with
saponin (1mg/mL, Sigma, St. Louis, MO) and double-stained
with two of the following antigens: anti-CD4-eFluor 450,
anti-IFN-𝛾-Alexa Fluor-488, anti-IL-17A-PE-Cy7, anti-TNF-
𝛼-PE, anti-IL-10-PerCp-Cy5.5 and anti-IL-4-APC, or anti-
CD8-FITC. For the immune cells subsets identification,
freshly collected dCLN cells were stained with anti-CD3-PE,
anti-B220-APC-Cy7, anti-CD4-FITC, and anti-CD8-APC.
For identification of activation, cells were stained with anti-
CD4-eFluor 450, anti-CD69-PerCp-Cy5.5, anti-CD44-APC,
and anti-CD62L-FITC.The stained cells were analyzed using
a BD LSRFortessa FACS machine with Flowjo software.
All antibodies were purchased from eBioscience (San Diego,
CA).
2.4. Statistical Analysis. Data are expressed as mean ± stan-
dard deviation (SD). A one-way ANOVAwith the Bonferroni
post hoc test was used for comparisons of two specific groups.
Differences were considered significant at 𝑝 < 0.05.
3. Results
3.1. Enhanced Immune Responses to Facial Nerve Injury in
SOD1𝐺93𝐴 Mice. Head injury is associated with an increased
risk for developing ALS [1–3], leading us to hypothesize
that inappropriate activation of the immune system from
prior injurymay underlie the development of ALS.Therefore,
in the current study, we used the FNA model of motor
neuron injury to compare immune responses in WT versus
SOD1G93A mice which serve as a mouse model of ALS
to examine underlying alterations in immune activation
and implications for disease development in SOD1G93A
mice (presymptomatic, 8-week-old B6SJL). As shown in
Figure 1(a), basal numbers (prior to the FNA) of total cells
recovered from one dCLNWTmouse were 6.13±0.44 (×106)
versus 12.1 ± 0.99 (×106) for SOD1G93A mice, suggesting that
SOD1G93Amice have greater baseline number of lymphocytes
than do WT mice. Following FNA, a transient increase in
the number of total cells recovered was noted in WT mice
and returned to basal levels at 14 days after FNA. In contrast,
SOD1G93A mice showed a progressive and sustained increase
in total cell numbers in the dCLN. Differences in cell counts
correlated with the size of dCLN in these mice (Figure 1(b)).
To further differentiate T cell subsets, we analyzed the
percentage of CD4+ versus CD8+ T cells (Figures 1(c)–1(e)).
Prior to the FNA, both WT and SOD1G93A mice had a
ratio of CD4 : CD8 that was approximately 2 : 1. Although
the ratio of CD4 : CD8 remained close to 2 : 1 in WT mice
following FNA, it decreased to a ratio approaching 1 : 1 in
SOD1G93A mice (Figures 1(c)-1(d)). However, because total
cell numbers in the dCLN increased after FNA, the absolute
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Figure 1: Continued.
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Figure 1: Inflammation and CD4 T cell activation in SOD1G93A mice. (a) Cervical lymph nodes were collected from uninjured (Con) and
axotomized WT and SOD1G93A mice at 7, 9, and 14 dpa. The average of total number of dCLN from one mouse was calculated and compared
(𝑛 = 4 mice/group). (b) dCLN from 3 individual mice in each group were collected and photographed on 7 dpa (the underline denotes the
horizontal dimension of each dCLN). (c) dCLN were gated on T cells (CD3+ cells) and further analyzed for their subsets: CD4+ and CD8+ T
cells. (d) the average of CD4+ and CD8+ T cell percentages in each group was calculated and compared. (e) The total numbers of CD4+ and
CD8+ T cells were calculated on the basis of the total number of corresponding dCLN and their percentages. (f) dCLN cells were gated on
CD4+ T cells and analyzed for CD69+ cells (in the square gate). (g) the average of CD69+ cell percentages in each group was calculated and
compared. (h)The total number of CD69+ cells was calculated on the basis of the total number of corresponding dCLN and their percentages.
(i) dCLN cells were gated on CD4+ T cells and analyzed for CD62LlowCD44high cells (in the square gate). (j) the average of CD62LlowCD44high
cell percentages in each group was calculated and compared. (k) The total number of CD62LlowCD44high cells was calculated on the basis of
the total number of corresponding dCLN and their percentages (data are presented as mean ± SD; 𝑛 = 4 mice/group, ∗𝑝 < 0.05; blue bars
represent uninjured animals, whereas gold bars represent animals that have been subjected to axotomy).
number of both CD4+ and CD8+ increased in both WT
and SOD1G93A (Figure 1(e)). These data suggest that an
enhanced basal level of inflammation in SOD1G93A mice
may impair immunoregulatory mechanisms that normally
dampen injury-induced inflammatory responses before the
onset of neurological symptoms.
3.2. Increased CD4+ T Cell Activation in Response to FNA.
CD4+ T cells play a crucial role in regulation of the immune
response. Accordingly, we examined further the activation
status of CD4+ T cell responses at 7 days after FNA, the
peak time of CD4+ T cell response [12]. In the WT mice, T
cells at both the early activation stage (CD69+, Figures 1(f)–
1(h)) and effector stage (CD62LlowCD44high, Figures 1(i)–
1(k)) were increased after FNA, as reflected by frequency
(Figures 1(g) and 1(j)) and total number (Figures 1(h) and
1(k)).The same patternwas also found in SOD1G93A mice, but
at a higher magnitude. In addition, FNA-induced activation
levels of CD4+ T cells in WT mice were comparable to
that of SOD1G93A mice prior to the FNA in terms of both
percentage and total number, suggesting that the FNA-
induced activation of T cells in WT mice may occur in a
similar manner as T cell activation in SOD1G93A mice, prior
to disease onset.
3.3. Th17 Cell Response in SOD1𝐺93𝐴 Mice. CD4+ T subsets
have distinct functions in terms of neuroprotective or neu-
rodestructive effects [10–15]. Therefore, we examined dCLN
CD4+ T subsets in WT and SOD1G93A mice at 7 days after
FNA by staining intracellularly for IFN-𝛾 (Th1 cells), IL-
17 (Th17 cells), TNF-𝛼 (pro-inflammatory cells), IL-4 (Th2
cells), and IL-10 (Treg cells). Following FNA, the frequency
ofTh1 cells in theWTmice was decreased, although the total
number did not significantly change. In contrast, both the
frequency and total number of Th1 cells were significantly
increased in SOD1G93A mice (Figures 2(a)-2(b), first column).
In addition, Th17 cells in the WT mice did not change in
frequency and increased only slightly in total number. In
contrast, SOD1G93A mice possessed both a greater frequency
and more total Th17 cells than did WT mice, regardless of
FNA state. In fact, the frequency of Th17 cells was 3-fold
higher (0.65 ± 0.05% versus 0.13 ± 0.03%) prior to injury
and was 4-fold higher (0.77 ± 0.02% versus 0.16 ± 0.02%)
after FNA (Figure 2(b), middle column) in SOD1G93A mice,
whereas the numbers of total Th17 cells were 9-fold higher
[2.8 ± 0.31 versus 0.28 ± 0.03 (×104)] prior to injury and 5-
fold higher [5.39 ± 0.61 versus 0.89 ± 0.14 (×104)] after FNA
(Figure 2(c) middle column) in SOD1G93A mice. In the WT
mice, the frequency and total number of Th1Th17 cells were
similar prior to and after FNA. In contrast, the frequency and
total number of Th1Th17 cells in SOD1G93A mice decreased
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Figure 2: Th17 cell responses in SOD1G93A mice. CD4+ T cells were isolated from dCLN from uninjured (Con) and axotomized WT and
SOD1G93A mice at 7 dpa (𝑛 = 4 mice/group). (a) Intracellular staining was performed for IFN-𝛾 and IL-17 and analyzed using FACS. (b)
The averaged percentages of Th1, Th17, and Th1Th17 cells in each groups were calculated and compared. (c) The averaged total number of
Th1, Th17, and Th1Th17 cells in each groups was calculated on the basis of the total number of corresponding dCLN and their percentages.
(d) Intracellular staining was performed for TNF-𝛼 and IL-17 and analyzed using FACS. (e) The averaged percentages of TNF-𝛼+ and TNF-
𝛼
+Th17 cells in each groups were calculated and compared. (f) The averaged total number of TNF-𝛼+ and TNF-𝛼+Th17 cells in each groups
was calculated on the basis of the total number of corresponding dCLN and their percentages (data are presented as mean ± SD; 𝑛 = 4
mice/group, ∗𝑝 < 0.05; blue bars represent uninjured animals, whereas gold bars represent animals that have been subjected to axotomy).
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after FNA. We did not find significant difference of Th2 and
Treg cells between WT and SOD1G93A mice prior to or after
FNA (data not shown).
Further analysis of TNF-𝛼 expression in CD4+ T cells
revealed that both frequency and percentage of TNF-𝛼-
single-positive cells were significantly increased in the WT
mice following FNA. However, in SOD1G93A mice, though
the percentage did not change after FNA, the total number
of TNF-𝛼+ cells significantly increased (Figures 2(e) and 2(f),
left column). TNF-𝛼-expressing Th17 (TNF-𝛼+Th17) in WT
mice was low in both frequency and total number and did
not significantly change after FNA. In contrast, TNF-𝛼+Th17
in SOD1G93A mice had a higher basal frequency and total
number which was further increased in response to FNA
(Figures 2(e) and 2(f), right column). These data suggest that
TNF-𝛼-expressingTh17 cells might be an important subset of
autoimmune cells involved in injury-induced inflammatory
damage in SOD1G93A mice.
4. Discussion
We have previously demonstrated that CD4+ T cells mediate
neuroprotection after nerve injury [4, 16]. In ALS, CD4+
T cells also play an important role in restricting disease
progression [13, 14]; however, this neuroprotection is in a
context- and subset-dependentmanner [10–15]. For example,
anti-inflammatory subsets of CD4+ T cells are generally
thought to be the types of neuroprotective immune cells
which support facial motoneuron survival after nerve injury
and may therefore slow down the disease progression in
ALS [10, 11]. Our previous studies revealed that multiple
subsets of CD4+ T cells develop following FNA in WT
mice, including both anti-inflammatory and proinflamma-
tory subsets of CD4+ T cells [12]. We hypothesize that the
balance between these subsets of CD4+ T is critical for the
resolution of necessary and beneficial inflammation as well
as induction of repair tissue and support mechanisms for
survival of damaged motoneurons. In the current work, we
used the SOD1G93A mice, an ALS mouse model, to show
that FNA induces significant motoneuron loss relative toWT
mice and that this loss is similar to that of immunodeficient
mice (Rag2−/− mice) [4, 16]. Exacerbation of FNA-induced
motoneuron loss in SOD1G93A mice may result from a poorly
controlled inflammatory response to injury, increased basal
levels of inflammation inherent to this model or perhaps to
failure of development of neuroprotective CD4+ T subsets
[4] as the current study revealed that there are significant
differences of FNA-induced immune responses betweenWT
and SOD1G93A mice.
First, we found that while WT mice mounted a well-
controlled immune response in the draining lymph nodes
following FNA, SOD1G93A mice had an enhanced and per-
sistent immune response as indicated by the enlarged size of
the draining lymph nodes as well as an increase in total cell
numbers. Further analysis for T cell subset responses revealed
that the ratio of CD4 : CD8T cells inWTmice did not change
in response to FNA,whereas the ratio decreased in SOD1G93A
mice. Because CD4+ T cells regulate CD8 T cell responses
and CD4+ T cells are the major type of T cells that impact
the neuronal survival after FNA, we focused on CD4+ T cell
responses in the analysis of T cell activation and subsets.
Our data indicate that activation of CD4+ T cells is higher
in SOD1G93A than WT mice. Regarding the subsets, we did
not find significant differences in anti-inflammatory T cell
subsets (Th2 andTreg cells) betweenWTand SOD1G93Amice
either prior to or after FNA; however, significant differences
were noted in the proinflammatory subsets (Th1 and Th17
cells) between these two types of mice. Without nerve injury,
Th1 cell frequency and total number were similar in WT and
SOD1G93A mice; however, FNA induced an increase in Th1
total number in SOD1G93A mice but not in WT mice. In the
uninjured state, both Th17 cell frequency and total number
were higher in SOD1G93A mice than in WT mice. Further
increases in Th17 cell frequency and total number were
noted in SOD1G93A mice but not in WT mice under FNA
injury conditions. Importantly, Th17 cells are also TNF-𝛼-
expressing cells in SOD1G93A mice but not inWTmice.These
data collectively indicate that feed-forward proinflammatory
response to injury occurs in SOD1G93A mice.
We recently demonstrated that whole splenocytes, but
not isolated CD4+ T cells, from WT mice can reduce FNA-
induced facial motor nucleus (FMN) loss in SOD1G93A mice
[4]. In addition, isolated CD4+ T cells, but not whole spleno-
cytes collected from SOD1G93A mice, are capable of support-
ing FMN survival in immunodeficient mice (Rag2−/−) [4].
These data suggest that the microenvironment in SOD1G93A
mice may direct CD4+ T cell differentiation into a neurode-
structive subset. Consistent with this hypothesis, the data
from the current study suggest that FNA-induced Th17 cell
responses in SOD1G93A mice may exacerbate neuroinflam-
mation, without a concomitant induction of the neural repair
phase, which in turn results in increased motoneuron death.
5. Conclusion
Enhanced CD4+ T cell activation and Th17 cell responses in
SOD1G93A mice exist prior to the onset of overt neurological
symptoms. Motor nerve injury further increases CD4+ T cell
activation and Th17 cell responses in SOD1G93A mice. We
therefore propose that cell-promoted inflammation may be
involved in the motoneuron death during ALS disease onset
and progression.
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